Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Emma Grace Loll
Observed names:
Emma G Loll,
Emma G. Loll,
Emma Loll
Institutions:
Uniformed Services University of the Health Sciences,
University of California Davis Medical Center,
University of California, Davis
Observed institutions:
Uniformed Services University of the Health Sciences,
Shriners Hospitals for Children - Northern California,
University of California Davis Medical Center,
UC Davis Health,
University of California, Davis
ORCID:
0009-0005-7021-4025
Observed ORCID:
0009-0005-7021-4025
OpenAlex ID:
A5037320278
Genetic and Molecular Determinants of Lymphatic Malformations: Potential Targets for Therapy
2022
·
Su Yeon Lee
, Emma Grace Loll
, et al.
·
Journal of Developmental Biology
·
30
PDF
Assessing the conjugation efficiency of surface-modified extracellular vesicles using single nanovesicle analysis technologies
2024
·
Leora Goldbloom-Helzner
, Harjn Bains
, et al.
·
Nanoscale
·
9
PDF
Targeting peptide homes to spinal cord injury in a rat model
2025
·
Jose A. Castillo
, Michael Nhien Le
, et al.
·
The Journal of Trauma: Injury, Infection, and Critical Care
·
1
Abstract 12931: Development of Novel Targeted, Membrane-Coated Polymer Hybrid Nanoparticles for Endothelial Repair Following Balloon Angioplasty in Rat Carotid Artery Model
2023
·
Lalithasri Ramasubramanian
, Nataliya Bahatyrevich
, et al.
·
Circulation
·
1
The intravenous targeted nanopeptide, CAQK, is neuroprotective and improves motor function after spinal cord injury in rats
2026
·
Jose A. Castillo
, Jay Uppuluri
, et al.
·
The Journal of Trauma: Injury, Infection, and Critical Care
Show more works
View as search
Works count:
5
Citation count:
41
H-index:
2
I10-index:
1
Year
Topic
Type